Valuation: Amedica Corporation

Market Cap 8.29M 7.27M 6.7M 6.27M 11.77M 782M 12.01M 80.56M 31.17M 387M 31.14M 30.46M 1.34B P/E 2026 *
-0.9x
P/E 2027 * -1.34x
Enterprise Value 8.29M 7.27M 6.7M 6.27M 11.77M 782M 12.01M 80.56M 31.17M 387M 31.14M 30.46M 1.34B EV / Sales 2026 *
3.6x
EV / Sales 2027 * 1.57x
Free-Float
65.08%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2007
President - 16/03/2026
Director of Finance/CFO 41 04/09/2025
Director TitleAgeSince
Director/Board Member 63 01/12/2007
Director/Board Member 63 03/04/2025
Director/Board Member 72 05/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 8.29M
+5.25%+8.09%-15.46%+11.37% 128B
-0.65%+1.20%+2.66%-8.37% 12.77B
+1.30%+10.51%+42.40%+107.74% 8.48B
-3.88%-6.41%-50.35%-72.89% 3.79B
-0.38%-0.97%+17.82%+35.38% 2.52B
-9.06%+4.50%+217.06%+145.62% 1.55B
-8.75%-13.25%-26.08%-23.32% 1.53B
-2.80%-3.48%-1.60%-24.54% 1.53B
Average -2.99%-0.05%+23.31%+21.37% 19.96B
Weighted average by Cap. +3.91%+6.82%-8.95%+13.91%

Financials

2026 *2027 *
Net sales 2.3M 2.02M 1.86M 1.74M 3.27M 217M 3.34M 22.38M 8.66M 107M 8.65M 8.46M 372M 5.27M 4.62M 4.26M 3.99M 7.47M 497M 7.63M 51.17M 19.8M 246M 19.78M 19.35M 852M
Net income -12.38M -10.85M -10M -9.37M -17.56M -1.17B -17.93M -120M -46.53M -577M -46.48M -45.47M -2B -11.38M -9.98M -9.19M -8.61M -16.14M -1.07B -16.48M -111M -42.76M -530M -42.72M -41.79M -1.84B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-